EmpiRx Health has announced Ziad Rubaie’s appointment as Chief Growth Officer. This makes EmpiRx Health the only industry-focused pharmacy benefits manager (PBM) that values value. Rubaie joins EmpiRx Health’s leadership team during a period of rapid expansion. He will continue to build on the momentum while plan sponsors search for financially sustainable, clinically-based health benefits.
Rubaie, a respected leader within the healthcare industry with over 27 years of experience building strong strategic partnerships through a network of highly skilled healthcare consultants. After three years at Consociate Health as Chief Business Development Officer, Rubaie joined EmpiRx Health to become the Chief Executive Officer of EmpiRx Health. This boutique TPA has a rapidly expanding national presence.
EmpiRx Health’s exciting year continues with the appointment of Rubaie to CGO. This value-based PBM was recently named a BenefitsPRO luminary for its work in transform the benefits business. It was also included on Fortune’s Best Workplaces In Healthcare(tm), and was awarded Great Place to Work(r), for the third year consecutively. EmpiRx Health published a unique data report entitled “Innovation in Pharmacy benefits: Mental Health is Health” this fall. It found that rising prescriptions for mental health do not necessarily mean higher costs. The findings of the report confirm that the PBM’s value-based, category-defining healthcare model can be balanced with cost and access.